---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-264143"
form_type: "8-K"
ticker: "SCLX"
cik: "0001820190"
company_name: "Scilex Holding Co"
filed_at: "2025-11-04T23:59:59+00:00"
generated_at: "2026-05-17T00:41:36.163575+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Scilex in-licenses Datavault AI tech for biotech asset tokenization; $10M upfront, $2.55B milestones

## Summary
- Worldwide exclusive license from Datavault AI for tokenizing genomic, DNA, diagnostic, therapeutic data in biotech/pharma.
- Non-refundable upfront fee $10M payable in four equal $2.5M quarterly installments starting Dec 31, 2025.
- Potential sales milestone payments up to $2.55B and 5% royalty on net sales; minimum annual royalty $1M after 24 months.
- Core patent includes 'Platform and Method for Tokenizing DNA Data' (U.S. Pat. App. 17/941,623) plus suite of issued/pending patents.
- Scilex aims to create a Biotech Exchange platform for secure tokenization, trading, and monetization of biotech assets.

## SEC filing metadata
- accession: 0001193125-25-264143
- form_type: 8-K
- ticker: SCLX
- cik: 0001820190
- company_name: Scilex Holding Co
- filed_at: 2025-11-04T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1820190/000119312525264143/0001193125-25-264143-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1820190/000119312525264143/sclx-20251104.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-264143
- JSON: https://secwatch.observer/filing/0001193125-25-264143.json
- Plain text: https://secwatch.observer/filing/0001193125-25-264143.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.